Quanterix Corporation (NASDAQ:QTRX) Given Average Recommendation of “Hold” by Brokerages

Shares of Quanterix Corporation (NASDAQ:QTRX) have been assigned a consensus rating of “Hold” from the five analysts that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $11.75.

Separately, Canaccord Genuity Group reissued a “hold” rating and set a $5.00 target price (down from $12.00) on shares of Quanterix in a research note on Monday, August 11th.

Quanterix Trading Up 2.0%

Shares of QTRX stock opened at $5.65 on Friday. The business’s fifty day simple moving average is $5.10 and its 200-day simple moving average is $5.55. The company has a market cap of $262.56 million, a PE ratio of -3.10 and a beta of 1.07. Quanterix has a 12-month low of $4.05 and a 12-month high of $15.67.

Quanterix (NASDAQ:QTRX) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.47) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.06). The company had revenue of $24.48 million for the quarter, compared to analysts’ expectations of $29.73 million. Quanterix had a negative net margin of 56.04% and a negative return on equity of 18.41%. Quanterix has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Quanterix will post -0.98 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Cetera Investment Advisers acquired a new stake in Quanterix in the 4th quarter valued at about $108,000. Deutsche Bank AG raised its holdings in Quanterix by 44.5% in the 4th quarter. Deutsche Bank AG now owns 35,726 shares of the company’s stock valued at $380,000 after acquiring an additional 11,004 shares during the last quarter. ProShare Advisors LLC acquired a new stake in Quanterix in the 4th quarter valued at about $108,000. Two Sigma Investments LP acquired a new stake in Quanterix in the 4th quarter valued at about $606,000. Finally, Two Sigma Advisers LP raised its holdings in Quanterix by 35.9% in the 4th quarter. Two Sigma Advisers LP now owns 36,748 shares of the company’s stock valued at $391,000 after acquiring an additional 9,700 shares during the last quarter. Institutional investors and hedge funds own 86.48% of the company’s stock.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.